Mirati Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mirati Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2023.
  • Mirati Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $35.1M, a 3.82% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $35.1M -$1.39M -3.82% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $35.4M -$1.39M -3.78% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $35.8M -$1.45M -3.88% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $36.1M -$1.58M -4.19% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 $36.5M -$1.71M -4.49% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $36.8M -$1.88M -4.86% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $37.2M -$2.05M -5.22% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $37.7M -$2.2M -5.51% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $38.2M +$37.6M +6262% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $38.7M +$38M +5429% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $39.3M +$38.9M +9720% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $39.9M +$39.3M +6756% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $600K +$259K +76% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $700K +$496K +243% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $400K +$113K +39.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $582K +$582K Dec 31, 2019 10-K 2021-02-25
Q3 2019 $341K Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $204K Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $287K Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.